Epstein-Barr virus: adaptation to a life within the immune system.
about
Identification of the WW domain-interaction sites in the unstructured N-terminal domain of EBV LMP 2ALatent membrane protein 2A of Epstein-Barr virus binds WW domain E3 protein-ubiquitin ligases that ubiquitinate B-cell tyrosine kinasesCrystal structure of human interleukin-10 at 1.6 A resolution and a model of a complex with its soluble receptorSpecificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopesType 2 cytokines predominate in the human CD4(+) T-lymphocyte response to Epstein-Barr virus nuclear antigen 1.Cytotoxic drug sensitivity of Epstein-Barr virus transformed lymphoblastoid B-cells.Mechanisms that regulate Epstein-Barr virus EBNA-1 gene transcription during restricted latency are conserved among lymphocryptoviruses of Old World primates.Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo.Tonsillar memory B cells, latently infected with Epstein-Barr virus, express the restricted pattern of latent genes previously found only in Epstein-Barr virus-associated tumors.Epidemiology of Epstein-Barr virus infection in pre-adolescent children: application of a new salivary method in Edinburgh, Scotland.Epstein-Barr virus oncogenesis and the ubiquitin-proteasome system.Interleukin-18, interferon-gamma, IP-10, and Mig expression in Epstein-Barr virus-induced infectious mononucleosis and posttransplant lymphoproliferative disease.Infection of human endothelial cells with Epstein-Barr virus.Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells.Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1.Inhibition of proteasomal degradation by the gly-Ala repeat of Epstein-Barr virus is influenced by the length of the repeat and the strength of the degradation signal.The signaling pathways of Epstein-Barr virus-encoded latent membrane protein 2A (LMP2A) in latency and cancer.Characterization of the CBF2 binding site within the Epstein-Barr virus latency C promoter and its role in modulating EBNA2-mediated transactivation.Epstein-barr virus regulates c-MYC, apoptosis, and tumorigenicity in Burkitt lymphoma.Cells expressing the Epstein-Barr virus growth program are present in and restricted to the naive B-cell subset of healthy tonsilsSpecific methylation patterns in two control regions of Epstein-Barr virus latency: the LMP-1-coding upstream regulatory region and an origin of DNA replication (oriP).Visualization of alternative Epstein-Barr virus expression programs by fluorescent in situ hybridization at the cell level.Detection of the latent form of Epstein-Barr virus DNA in the peripheral blood of healthy individuals.Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cellComprehensive profiling of Epstein-Barr virus microRNAs in nasopharyngeal carcinoma.Large clonal expansions of CD8+ T cells in acute infectious mononucleosis.A repetitive sequence of Epstein-Barr virus nuclear antigen 6 comprises overlapping T cell epitopes which induce HLA-DR-restricted CD4(+) T lymphocytes.The ecology and pathology of Epstein-Barr virus.Murine cytotoxic T lymphocytes recognize an epitope in an EBNA-1 fragment, but fail to lyse EBNA-1-expressing mouse cells.Epstein-Barr virus nuclear antigen 2 is a transcriptional suppressor of the immunoglobulin mu gene: implications for the expression of the translocated c-myc gene in Burkitt's lymphoma cells.Direct identification by PCR of EBV types and variants in clinical samples.The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo.Breastfeeding, previous Epstein-Barr virus infection, Enterovirus 71 infection, and rural residence are associated with the severity of hand, foot, and mouth disease.A longer stay for the kissing disease: epidemiology of bacterial tonsillitis and infectious mononucleosis over a 20-year period.A minimal glycine-alanine repeat prevents the interaction of ubiquitinated I kappaB alpha with the proteasome: a new mechanism for selective inhibition of proteolysis.Epstein-Barr virus DNA in serum after liver transplantation--surveillance of viral activity during treatment with different immunosuppressive agents.Epstein-Barr virus genomes are found predominantly in IgA-positive B cells in the blood of healthy carriers.Clonal CD8+ lymphocytic proliferation associated with Epstein-Barr virus infection mimicking T-cell leukemia.The Epstein-Barr virus nuclear antigen 2 (EBNA2), a protein required for B lymphocyte immortalization, induces the synthesis of type I interferon in Burkitt's lymphoma cell lines.
P2860
Q24337193-EA5E88DC-6509-47B9-B030-BBCA4E0C8159Q24515076-6743F971-8A4B-4073-BFAC-F31C0A06037EQ24674762-03D90499-7E2C-4D88-8D41-F0AA5CA7C2E6Q24792319-8430C4F8-BC7B-4948-A3FD-B76E4397F1FEQ30305830-198DCBFE-C583-4215-AED8-EFE6EAF243D2Q33263443-2C16861B-93CD-47AF-90E5-6BFF19BA0AC1Q33653017-471275EC-8FD3-42EE-968E-161B4515D9A4Q35122260-36FE925B-FEED-4B10-B7EF-73CCDDF94815Q35414637-BD212923-9AE1-4D48-963E-50E2BF6FB1B2Q35558131-F3E1D692-0125-46CA-9441-25E5C030B0CEQ35691576-F843B03A-8917-4013-B7F0-6C69A3157527Q35787184-90A6603B-2817-4DD1-AF6F-A1F6E160642EQ36365385-6CECAAB2-CFEB-43A8-A2E2-5DB574D20F94Q36367286-2A85DB7E-EC0C-4D8A-8E27-5B44A9650608Q36826932-365D3321-AFDA-4919-A87A-50DD3863B54CQ37225439-5FBD2887-C565-4DFF-8218-6761DB4C9A92Q37350748-301EB0C9-66A7-4F85-9CB2-3C33D33F5856Q38341023-DF4AED2C-3D38-4904-97E2-C21B0AEE60D2Q39444685-622D1349-6DA7-4A03-95A4-1BBC72054C90Q39539494-45FDAD4B-86E3-4733-9AB2-B9E07C5A4AC5Q39579096-AF6596F2-47E1-4FB5-A49D-DCA3D1A41DD7Q39594222-45A19035-6E7B-490D-AB23-AEBCF7E89BA8Q39874449-DF78D947-E9CC-478B-88A5-1751701BE619Q39880077-EDF306AF-5C9C-4009-9F53-B36D65A34AA3Q39903979-F9BD8298-6B2D-47AF-9AB6-431966847128Q40665903-607591EF-DFE0-455B-97CD-60A2B9C91F21Q40896159-DDDFAC78-0731-434E-8728-C619D0D8F85FQ41036904-43EBDA30-2B7F-486C-B3F7-063B7C9FCCBEQ41059342-F9234A7D-A795-496B-A4C6-C7F7F331C99BQ41063703-D91422CB-5A2D-491F-9D01-7EA833B39E42Q41119648-87EA57EF-FF14-4A01-B3E9-D00CA1236362Q41223097-3805436F-CA6E-445F-A84D-0CA7D9F4D362Q41764334-6A79FCA1-BA49-4312-9C1E-6E0459C727FAQ42277791-7C87C6E0-9CD0-4421-AEEB-0B35B74104B5Q42280044-E8659E9E-0249-40AB-A90A-80BB4971B504Q42459737-0D53B22B-FD4A-42FB-8745-C4EFBFB005AFQ44483769-17C5D5EC-7BFB-4738-A680-A0DAB0123799Q44654555-424619F4-0B9D-4B6D-8005-76DC7FF91C8EQ45018508-1F5788F1-17F9-407C-A590-A5B72E76DA2AQ45750207-42369E23-ACCB-433F-867E-0EBE382CB09E
P2860
Epstein-Barr virus: adaptation to a life within the immune system.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Epstein-Barr virus: adaptation to a life within the immune system.
@en
type
label
Epstein-Barr virus: adaptation to a life within the immune system.
@en
prefLabel
Epstein-Barr virus: adaptation to a life within the immune system.
@en
P1476
Epstein-Barr virus: adaptation to a life within the immune system.
@en
P2093
P304
P356
10.1016/0966-842X(94)90599-1
P577
1994-04-01T00:00:00Z